|3D model (Jmol)||Interactive image
|Molar mass||150.13 g/mol|
|Appearance||Colorless crystals as prisms or needles|
|Density||1.585 g/cm3 (20 ºC)|
|Melting point||164 to 165 °C (327 to 329 °F; 437 to 438 K)|
|834 g/1 L (25 °C (77 °F))|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
For biosynthetic reasons, most saccharides are almost always more abundant in nature as the "D"-form, or structurally analogous to D-glyceraldehyde.[note 1] However, L-arabinose is in fact more common than D-arabinose in nature and is found in nature as a component of biopolymers such as hemicellulose and pectin.
The L-arabinose operon, also known as the araBAD operon, has been the subject of much biomolecular research. The operon directs the catabolism of arabinose in E. coli, and it is dynamically activated in the presence of arabinose and the absence of glucose.
Use in biology
In synthetic biology, arabinose is often used as a one-way or reversible switch for protein expression under the Pbad promoter in E. coli. This on-switch can be negated by the presence of glucose or reversed off by the addition of glucose in the culture medium which is a form of catabolite repression.
Some organic acid tests check for the presence of arabinose, which may indicate overgrowth of intestinal yeast such as Candida albicans or other yeast/fungus species.
Use in foods
Originally commercialized as an sweetener, arabinose is an inhibitor of sucrase, the enzyme that breaks down sucrose into glucose and fructose in the small intestine. This inhibitory effect has been validated both in rodents and humans. Therefore, arabinose could be used in foods to attenuate the peak of glycemic response after the consumption of sucrose. The long-term effects of arabinose consumption on blood glucose parameters such as HbA1c and fasting blood glucose levels are unknown. Foods that contain arabinose are usually designed for prediabetic and diabetic patients. These foods are especially popular in Japan and China, where arabinose is legally used as an food additive.
Arabinose is a potential prebiotic, because it cannot be absorbed by human intestine and could be utilized by probiotics such as bifidobacteria. This claim requires further validation.
- For sugars, the D/L nomenclature does not refer to the molecule's optical rotation properties but to its structural analogy to glyceraldehyde.
- Weast, Robert C., ed. (1981). CRC Handbook of Chemistry and Physics (62nd ed.). Boca Raton, FL: CRC Press. p. C-110. ISBN 0-8493-0462-8.
- Watson, James (2003). Molecular Biology of the Gene. p. 503.
- Braun, Géza (1940). "D-Arabinose". Org. Synth. 20: 14.; Coll. Vol., 3, p. 101
- Merriam Webster Dictionary
- Guzman LM, Belin D, Carson MJ, Beckwith J. (July 1995). "Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter.". J Bacteriol. 177 (14): 4121–30. doi:10.1128/jb.177.14.4121-4130.1995.
- Krog-Mikkelsen, Inger; Hels, Ole; Tetens, Inge; Holst, Jens Juul; Andersen, Jens Rikardt; Bukhave, Klaus (2011-08-01). "The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans". The American Journal of Clinical Nutrition. 94 (2): 472–478. doi:10.3945/ajcn.111.014225. ISSN 1938-3207. PMID 21677059.
- Seri, K.; Sanai, K.; Matsuo, N.; Kawakubo, K.; Xue, C.; Inoue, S. (1996-11-01). "L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals". Metabolism: Clinical and Experimental. 45 (11): 1368–1374. doi:10.1016/s0026-0495(96)90117-1. ISSN 0026-0495. PMID 8931641.
- Degnan, B. A.; Macfarlane, G. T. "Transport and metabolism of glucose and arabinose in Bifidobacterium breve". Archives of Microbiology. 160 (2): 144–151. doi:10.1007/BF00288717. ISSN 0302-8933.